Oxomollugin, a potential inhibitor of lipopolysaccharide-induced nitric oxide production including nuclear factor kappa B signals

Hiroshi Morita(Hoshi University), Yukihiro Goda(National Institute of Health Sciences), Yoshiaki Kakubari(Hoshi University), Yuki Nakajima(Fujisawa City Hospital), Asami Nakata(Hoshi University), Yoko Kawasaki(National Institute of Health Sciences), Jun Deguchi(Hoshi University), Hitomi Nishino(Hoshi University), Yusuke Hirasawa(Hoshi University), Toshio Kaneda(Osaka City General Hospital), Alfarius Eko Nugroho(Hoshi University)
Journal of Natural Medicines
June 30, 2015
Cited by 10


Related Papers